• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Rare Diseases

    Crinetics Initiates Ph 3 For Paltusotine in Carcinoid Syndrome

    GLOBENEWSWIRE

    Orsini Chosen As Crinetics` Palsonify Specialty Pharmacy Partner

    PR NEWSWIRE

    FDA Grant Crinetics Orphan Status for Atumelnant in CAH Treatment

    GLOBENEWSWIRE

    Crinetics Pharma`s MAA, ODD For Paltusotine In Acromegaly Validated

    GLOBENEWSWIRE

    Crinetics` stock jumps following promising Ph2 data in four patients

    ENDPTS

    Crinetics blindsided by nonclinical data that sink orphan drug

    FIERCE BIOTECH

    Quotient Sciences Supports Crinetics Pharmaceuticals with Fully Integrated Pediatric Development and Clinical Testing Program

    PR NEWSWIRE

    Crinetics Receives Rare Pediatric Disease Designation for CRN04777

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.